Capstone Investment Advisors’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Capstone Investment Advisors’s Portfolio IDIX Stock Details IDIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-12,500	Closed	-$301K	–	545
2014 Q2	$301K	Buy	+12,500	New	+$130K	﹤0.01%	368

Capstone Investment Advisors's IDIX Position: Q3 2014 in Review

Capstone Investment Advisors sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 12,500 shares — an estimated $301K sold.

Capstone Investment Advisors first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $301K in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

Capstone Investment Advisors reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
Capstone Investment Advisors sold 12,500 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $301K.
Capstone Investment Advisors first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
Capstone Investment Advisors's IDENIX PHARMACEUTICALS INC position peaked at $301K in Q2 2014.
0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Capstone Investment Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.